Harvard University / Massachusetts General Hospital Center for Cancer Research, United States
Debattama (Deb) Sen is an Assistant Professor at Harvard Medical School and the Krantz Family Center for Cancer Research at Massachusetts General Hospital. The Sen laboratory investigates the regulation of T cell dysfunction and explores epigenetic approaches for T cell engineering. This work lies at the interface of human immunology, systems biology, and functional epigenomics – merging clinical observations with mechanistic mouse studies to develop novel therapeutic strategies. Dr. Sen's work has been recognized with a NextGen Star Award from the American Association of Cancer Research (AACR), a Young Investigator Award from the Melanoma Research Alliance, a V Foundation Scholar Award as well as the NIH Director's Young Innovator Award.
FRONTIERS IN EPIGENETIC CONTROL FOR ENHANCED STEM CELL THERAPIES
Wednesday, July 10, 2024
4:00 PM – 5:30 PM CEST